Origin House

OH

CA1376441004

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-7.47%	-10.42%

2021	Spyder Cannabis Inc. completed the acquisition of 180 Smoke LLC from Origin House for CAD 1.	CI
2021	Spyder Cannabis Inc. entered into a binding agreement to acquire 180 Smoke LLC from Origin House.	CI

Origin House Provides Revenue Guidance for the First Quarter of 2019

April 29, 2019 at 08:30 am

Origin House provided revenue guidance for the first quarter of 2019. For the period, the company expects a solid sequential revenue growth.

Latest news about Origin House

Spyder Cannabis Inc. completed the acquisition of 180 Smoke LLC from Origin House for CAD 1.	21-03-29	CI
Spyder Cannabis Inc. entered into a binding agreement to acquire 180 Smoke LLC from Origin House.	21-02-22	CI
Driven Deliveries, Inc. cancelled the acquisition of Humboldt's Finest Farms.	21-01-27	CI
Driven Deliveries, Inc. signed a letter of intent to acquire Humboldt's Finest Farms.	20-01-27	CI
Cresco Labs Inc. (CNSX:CL) completed the acquisition of Origin House (CNSX:OH).	20-01-07	CI
Origin House Strengthens Partnership with Kings Garden Inc	19-12-30	CI
Tranche Update on Origin House's Equity Buyback Plan announced on August 9, 2018.	19-11-28	CI
Origin House announced that it has received CAD 39.599999 million in funding	19-11-25	CI
Origin House announced that it expects to receive CAD 39.599999 million in funding	19-11-12	CI
Origin House Announces Full Integration with California Cannabis Track-and-Trace System	19-10-15	CI
An unknown acquired Distribution and Manufacturing Facility in Sonoma County from Origin House (CNSX:OH) for $1.7 million.	19-10-14	CI
Cannaroyalty Corp. Signs Distribution Agreement with California Cannabis Infused Beverage Brand Cannabiniers	19-10-03	CI
Origin House Announces Executive Changes	19-10-03	CI
Origin House Announces Additional CAD 15 Million Tranche of Debt Financing from Opaskwayak Cree Nation	19-09-20	CI
Origin House Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-29	CI
Tranche Update on Origin House's Equity Buyback Plan announced on August 9, 2018.	19-08-29	CI
Origin House's Equity Buyback announced on August 9, 2018, has expired.	19-08-12	CI
Zola Global Investors, Ltd. and other investors acquired 5.1% stake in Alternative Medical Enterprises, LLC for $6 million.	19-07-25	CI
Origin House Announces Preliminary Unaudited Revenue Results for the Second Quarter Ended June 30, 2019	19-07-18	CI
Origin House Provides Update on Debt Financing	19-07-02	CI
Origin House Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019	19-05-29	CI
Tranche Update on Origin House's Equity Buyback Plan announced on August 9, 2018.	19-05-28	CI
Origin House Reports Preliminary Unaudited Revenue Results for the Month of April 2019 and First Quarter Ended March 31, 2019	19-05-17	CI
Origin House cancelled the transaction announced on March 5, 2019	19-05-16	CI
Origin House (CNSX:OH) completed the acquisition of certain business assets of Cub City LLC for $5.3 million.	19-05-01	CI

CannaRoyalty Corp., doing business as Origin House, is a Canada-based company. The Company is growing cannabis brands and distribution company in United States and Canada. The Company acts as a brand development platform by distribution, manufacturing, cultivation, and marketing services for it's clients. The Company is also developing infrastructure to support their customers.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
ORIGIN HOUSE	-10.42%	352M
DONG-E-E-JIAO CO.,LTD.	+39.27%	6.07B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.60%	4.42B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.27%	3.26B
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.69%	3B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.88%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+43.78%	1.89B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-11.89%	1.63B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.67%	1.6B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.39%	1.54B

Alternative Medicine

Origin House

Equities

OH

CA1376441004

Pharmaceuticals

Origin House Provides Revenue Guidance for the First Quarter of 2019

Latest news about Origin House

Chart Origin House

Company Profile

Sector Alternative Medicine